Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

TIGD2 Inhibitors

The chemical class of TIGD2 Inhibitors is defined by a group of compounds selected for their ability to modulate the function and expression of TIGD2, a gene found in transposable elements. This class is characterized not by a uniform chemical structure, but rather by a shared functional goal: influencing TIGD2's role in genomic regulation and gene expression. These inhibitors operate through various indirect mechanisms, reflecting the intricate nature of TIGD2's involvement in cellular processes such as chromatin remodeling, transcription regulation, and epigenetic modifications. The modes of action are tailored to interact with different stages of the regulatory processes in which TIGD2 is involved, aiming to modulate its functionality within the genome.

The primary approach of these inhibitors is the indirect disruption or modification of the biochemical pathways and processes essential for TIGD2's activity. This disruption occurs through altering the epigenetic landscape surrounding the TIGD2 gene, which can include changes in DNA methylation patterns and histone modifications. By targeting key components such as enzymes responsible for adding or removing epigenetic marks, the inhibitors can change the chromatin state, affecting the expression of TIGD2. Additionally, some compounds in this class focus on modulating the transcription machinery directly or indirectly. This can involve inhibiting RNA polymerase activity, affecting transcription factors, or influencing other molecules involved in the transcriptional regulation of TIGD2. By altering these factors, the inhibitors can impact the transcriptional output of the TIGD2 gene, thereby influencing its role in cellular processes. The TIGD2 Inhibitors class represents a sophisticated approach to influencing a specific gene's function by intervening in broader biological processes. It underscores the complex interplay between chemical entities and genetic regulation, highlighting the depth of understanding required to manipulate gene expression within complex biological networks. This class of inhibitors exemplifies the potential of targeted molecular intervention in genomic regulation, demonstrating the ability to influence key aspects of gene expression and chromatin dynamics. By focusing on the modulation of genes found in transposable elements and their associated regulatory pathways, these inhibitors offer insights into the mechanisms of genomic regulation and the role of such genes in cellular function and genomic integrity.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

α-Amanitin

23109-05-9sc-202440
sc-202440A
1 mg
5 mg
$269.00
$1050.00
26
(2)

Alpha-Amanitin inhibits RNA polymerase II, potentially decreasing the transcription of TIGD2 by limiting mRNA synthesis.

Suberoylanilide Hydroxamic Acid

149647-78-9sc-220139
sc-220139A
100 mg
500 mg
$133.00
$275.00
37
(2)

Another histone deacetylase inhibitor, Suberoylanilide Hydroxamic Acid can modify chromatin structure, which might impact TIGD2 expression by altering gene accessibility.

RG 108

48208-26-0sc-204235
sc-204235A
10 mg
50 mg
$131.00
$515.00
2
(1)

RG108, a DNA methyltransferase inhibitor, could affect the methylation status of the TIGD2 gene, potentially influencing its transcription.

5-Aza-2′-Deoxycytidine

2353-33-5sc-202424
sc-202424A
sc-202424B
25 mg
100 mg
250 mg
$218.00
$322.00
$426.00
7
(1)

5-Aza-2′-Deoxycytidine reduces DNA methylation levels, which could lead to changes in TIGD2 expression by affecting the epigenetic regulation of its genomic region.

Mithramycin A

18378-89-7sc-200909
1 mg
$55.00
6
(1)

As an inhibitor of the Sp1 transcription factor, Mithramycin A might indirectly affect TIGD2 expression if Sp1 is involved in its regulatory pathway.

MS-275

209783-80-2sc-279455
sc-279455A
sc-279455B
1 mg
5 mg
25 mg
$24.00
$90.00
$212.00
24
(2)

MS-275 affects histone acetylation, potentially influencing TIGD2 expression by altering chromatin structure and gene accessibility.

Panobinostat

404950-80-7sc-208148
10 mg
$200.00
9
(1)

Panobinostat, a potent histone deacetylase inhibitor, can modify chromatin structure, potentially affecting the expression of TIGD2.